Use of zoledronic acid in antiosteoporosis treatment is associated with a decreased blood lipid level in postmenopausal women with osteoporosis: A cohort study in China-MedSci.cn

Use of zoledronic acid in antiosteoporosis treatment is associated with a decreased blood lipid level in postmenopausal women with osteoporosis: A cohort study in China

Luo, W; Zhang, J; Xu, L; Zhou, Y; Xu, D; Lv, QJ; Xiao, Y; Yang, Q

Luo, W; Zhang, J (通讯作者)，Peoples Hosp Leshan, Dept Endocrinol, Leshan City, Sichuan, Peoples R China.;Xu, L (通讯作者)，Southwest Med Univ, Affiliated Hosp, Dept Endocrinol, Luzhou City, Sichuan, Peoples R China.

Abstract

Objective This cohort study aimed to evaluate the protective effects of zoledronic acid (ZA) in lipidemia in postmenopausal women with osteoporosis. M......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Use of zoledronic acid in antiosteoporosis treatment is associated with a decreased blood lipid level in postmenopausal women with osteoporosis: A cohort study in China

科室

工具

服务